BridgeBio Pharma, Inc 10-K for FY2020
BridgeBio Pharma, Inc. (BBIO)
10-K
2021-02-25
For: 2020-12-31
View Original
Added on
April 08, 2026
About this 10-K
BridgeBio Pharma, Inc filed this 10-K on February 25, 2021, covering the fiscal year ended December 31, 2020 (FY2020).
Headline figures
Fiscal year ended December 31, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $8.25M
- down 79.7% from $40.56M a year earlier
- Net loss
- $505.49M
- compared with a net loss of $288.59M a year earlier